XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
3.300
+0.160 (5.10%)
Aug 14, 2025, 1:43 PM - Market open
XBiotech Market Cap
XBiotech has a market cap or net worth of $100.61 million as of August 14, 2025. Its market cap has decreased by -54.37% in one year.
Market Cap
100.61M
Enterprise Value
-57.21M
1-Year Change
-54.37%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $100.61M, a decrease of -86.36%. That is a compound annual growth rate of -17.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 90.50M | -24.83% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |